openPR Logo
Press release

CD BioSciences Announces DS IHC Kits for Human and Rodent Tissues

11-25-2024 08:14 PM CET | Health & Medicine

Press release from: ABNewswire

CD BioSciences Announces DS IHC Kits for Human and Rodent Tissues

CD BioSciences has announced the release of its new DS IHC Kits for researchers.
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, has announced the release of its new DS IHC Kits [https://www.bioimagingtech.com/ds-ihc-kits-for-human-and-rodent-tissues.html] for researchers working with human and rodent tissues. Developed to streamline the immunohistochemistry (IHC) staining process, these kits can provide researchers with a reliable and efficient tool for visualizing specific proteins in tissue samples.

CD BioSciences provides multi-color immunohistochemical staining kits that leverage either ABC (avidin-biotin complex) or polymer signal amplification techniques, facilitating the staining of tissues and cells in 2-3 distinct colors. These innovative kits are engineered to deliver superior quality and are specifically optimized for use with human and rodent samples. The new DS IHC Kits are compatible with a wide range of human and rodent tissues, including formalin-fixed, paraffin-embedded (FFPE) tissues and frozen tissues. These kits are ideal for researchers and clinicians who need a reliable and easy-to-use method for IHC staining.

For example, the 2-Color IHC Kit for 2 Rabbit Antibody on Human/Rodent Tissue (Catalog NO. MCIS063) is a versatile tool for immunohistochemistry, suitable for a variety of sample types including paraffin-embedded tissue, frozen samples and freshly prepared monolayer cell smears. Double staining is a common technique in immunohistochemistry that allows the simultaneous detection and differentiation of two different antigens within a single tissue sample. This kit is specifically designed for double staining applications and uses DAB (brown) and Fast Red (red) dyes to visualize two different antigens on human and mouse tissue or cell samples when combined with user-supplied rabbit primary antibodies.

In addition, the kit contains essential components for successful double staining. These include two polymer-enzyme conjugates: HRP Polymer Anti-Rabbit IgG and AP Polymer Anti-Rabbit IgG. These conjugates are coupled to two chromogenic substrates: DAB (used with HRP polymer anti-Rabbit IgG) and Fast Red (used with AP polymer anti-Rabbit IgG), which produce brown and red staining, respectively. The kit uses a non-biotin system to minimize non-specific binding.

The 2-Color IHC Kit for Goat/Rat Antibody on Human/Mouse Tissue (Catalog NO. MCIS070) uses two primary antibodies, goat and rat, to target two different antigens. To visualize these antigens, the kit contains two polymer-enzyme conjugates: HRP polymer anti goat IgG and AP polymer anti rat IgG. These conjugates are coupled to two different chromogens: AEC (red) and BCIP/NBT (purple). Sequential application of these conjugates allows the kit to detect both antigens simultaneously. If both antigens are present, a distinct purple/red colour develops. However, if only one antigen is present, either red or purple staining will be observed. Importantly, this non-biotin system minimizes background noise and ensures specific staining.

CD BioSciences provides innovative solutions that enable researchers to make groundbreaking discoveries. The DS IHC Kits are the latest addition to the company's comprehensive portfolio of life science products and services. To learn more about the new Multicolor Immunohistochemical Staining Kits, please visit https://www.bioimagingtech.com/ds-ihc-kits-for-human-and-rodent-tissues.html.

About CD BioSciences

CD BioSciences is a biotechnology company committed to the development of imaging technology for many years. Its scientists can utilize high-content imaging, nanoparticle imaging, imaging flow cytometry, time-lapse imaging, and other techniques to image cell structure, cell migration, cell proliferation, pathogen infection mechanisms, and interactions between protein molecules.

Media Contact
Company Name: CD BioSciences
Contact Person: Michelle Moser
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cd-biosciences-announces-ds-ihc-kits-for-human-and-rodent-tissues]
State: New York
Country: United States
Website: https://www.bioimagingtech.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release CD BioSciences Announces DS IHC Kits for Human and Rodent Tissues here

News-ID: 3755093 • Views:

More Releases from ABNewswire

Ecosense Expands U.S. Market with BestBuy.com Launch
Ecosense Expands U.S. Market with BestBuy.com Launch
Radon Detection Leader Now Makes Complete Line of Smart Digital Radon Monitors Available to American Consumers San Jose, CA - August 28, 2025 - Ecosense [https://ecosense.io/], the global leader in radon detection and monitoring solutions, is pleased to announce that its award-winning residential radon monitors can now be purchased on BestBuy.com in the United States. Following its launch with Best Buy Canada the year before last, this announcement is the second
Graft vs Host Disease Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Cellestia Biotech, Pfizer, Chia Tai Tianqing Pharma, Regimmune Corp
Graft vs Host Disease Pipeline 2025: FDA Updates, Therapy Innovations, and Clini …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Graft vs Host Disease pipeline constitutes 45+ key companies continuously working towards developing 50+ Graft vs Host Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Graft vs Host Disease Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/graft-versus-host-disease-gvhd-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Graft
Hearthfire Holdings Increases Chicago Metro Footprint with Crest Hill Self-Storage Development Purchase
Hearthfire Holdings Increases Chicago Metro Footprint with Crest Hill Self-Stora …
Philadelphia-Based Investment Company Acquires Fourth Chicago-Area Property, Forms Joint Venture with Condev Land and Development Group PHILADELPHIA, PA - August 28th, 2025 - Hearthfire Holdings [https://hfirecapital.com/], a real estate investment company focused on self-storage assets, today announced another closed Joint Venture with the purchase of a shovel-ready development site in Crest Hill, Illinois, its fourth project in the Chicago metro market. The purchase kicks off a joint venture partnership with Condev Land
Chronic Hepatitis B Virus Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Ascletis Pharma, Shanghai HEP Pharma, Romark Lab, Qilu Pharma
Chronic Hepatitis B Virus Pipeline 2025: MOA and ROA Insights, Clinical Trials S …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Chronic Hepatitis B Virus pipeline constitutes 50+ key companies continuously working towards developing 55+ Chronic Hepatitis B Virus treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Chronic Hepatitis B Virus Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/chronic-hepatitis-b-virus-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Chronic

All 5 Releases


More Releases for IHC

Top Factor Driving Immunohistochemistry (IHC) Market Growth in 2025: Increase In …
What market dynamics are playing a key role in accelerating the growth of the immunohistochemistry (ihc) market? The immunohistochemistry (IHC) market is projected to grow due to the escalating occurrence of chronic illnesses. Chronic ailments are medical conditions that typically last for at least three months and can typically be managed but not completely cured. Immunohistochemistry proves beneficial in diagnosing such diseases including cancer, cardiovascular conditions, and others due to its
Top Factor Driving Immunohistochemistry (IHC) Market Growth in 2025: Increase In …
What market dynamics are playing a key role in accelerating the growth of the immunohistochemistry (ihc) market? The immunohistochemistry (IHC) market is projected to grow due to the escalating occurrence of chronic illnesses. Chronic ailments are medical conditions that typically last for at least three months and can typically be managed but not completely cured. Immunohistochemistry proves beneficial in diagnosing such diseases including cancer, cardiovascular conditions, and others due to its
Immunohistochemistry (IHC) Market: Size, Share, Forecast, and Trends
Meticulous Research®, a leading global market research firm, has released a comprehensive new report titled "Immunohistochemistry (IHC) Market Size, Share, Forecast, & Trends Analysis by Offering (Reagents [Fixation, Buffer, Blocking, Antibodies], Kits, Equipment [Staining, Imaging]), Method (ABC, CSA, PAP), Process, Application, End User-Global Forecast to 2031." Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5967 This detailed analysis highlights that the global immunohistochemistry market is on track to reach an estimated $4.08 billion by 2031,
Immunohistochemistry (IHC) Market Report 2024: Strategies And Recent Development …
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2404 The Business Research Company offers in-depth market insights through Immunohistochemistry (IHC) Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments. Market Size And Growth Forecast: The immunohistochemistry (ihc) market size has grown strongly in recent years. It
Immunohistochemistry (IHC) Market Trends, Top Companies, Share, Growth And Forec …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 Immunohistochemistry (IHC) Market Size, Growth Rate, And Forecast The global immunohistochemistry (IHC) market size is expected to grow from $2.23 billion in 2022 to $2.41 billion in 2023 at a compound annual growth rate (CAGR) of 8.1%. The Russia-Ukraine war disrupted the chances of global economic recovery
Immunohistochemistry (IHC) Market Size, Trends, Share | Industry Growth - 2030
The most recent study offered by Acumen Research and Consulting focuses Immunohistochemistry (IHC) Market size, share, growth rate, and market trends, as well as the parameters and factors influencing it in both the long term and short term. The report investigates the Immunohistochemistry (IHC) Market trends in order to assess its current and future potential. Our Immunohistochemistry (IHC) Market analysis also provides market participants and new entrants with a comprehensive